Biotech

All Articles

Eli Lilly hops deeper into AI with $409M Hereditary Surge deal

.Eli Lilly has actually vaulted right into an AI-enabled drug discovery deal, partnering with RNA pr...

After FDA turndown as well as unemployments, Lykos chief executive officer is actually leaving

.Lykos chief executive officer as well as founder Amy Emerson is actually walking out, along with ch...

Novartis fires up brand-new phase of Voyager pact with $15M capsid package

.Novartis levels a new outpost in its own cooperation along with Voyager Therapies, paying for $15 t...

Lilly articles extra good data on its weekly insulin possibility

.On the heels of an FDA rejection for its chief rivalrous Novo Nordisk, Eli Lilly is actually pushin...

IN 8bio stops phase 2 test, gives up one-half of workforce

.Simply a handful of months after application the first patient in a stage 2 trial for newly diagnos...

Lilly, Haya ink $1B biobuck weight problems deal to browse darker genome

.Eli Lilly's look for obesity aim ats has actually led it to the darker genome. The Big Pharma has a...

ArsenalBio elevates $325M, pivots off of former lead asset

.Toolbox Biosciences is carrying on up. The cell therapy provider has added on $325 million in ammun...

Lilly- backed fat loss biotech reports IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has filed to ...

Aelis' marijuana usage drug fails period 2b, steering Indivior to review $100M possibility

.Aelis Farma's hopes of protecting an easy, favorable decision on a $100 million option settlement h...

ProKidney halts period 3 test certainly not needed to have for tissue treatment authorization

.ProKidney has quit among a pair of phase 3 trials for its own cell treatment for renal disease afte...